(firstQuint)Evaluation of the Utility of Minocycline as an Anti-Inflammatory Agent in the Treatment of Asthma.

 This is a double-blind, placebo-controlled crossover study of adult asthmatics given minocycline 150 mg po BID or placebo as add-on therapy for eight weeks each.

 Each eight week arm is separated by a four week wash-out.

 Spirometry is performed at the baseline and end of each arm.

 Daily symptoms scores, peak flow rates, and oral steroid requirements are recorded.

 A standardized asthma quality of life symptoms assessment is made every four weeks (AQLQ, Juniper).

.

 Evaluation of the Utility of Minocycline as an Anti-Inflammatory Agent in the Treatment of Asthma@highlight

Trial of effects of minocycline as "add-on" therapy to adults with asthma with a history of requiring at least one episode of oral steroid therapy to control the disease.

